References
- Leung B S. Role of estrogen in the induction of carcinogenesis and the promotion of tumor growth. Hormonal Regulation of Mammary Tumors, B S Leung. Eden Press, Montreal 1982; vol. I: 36–72
- Leung B S, Krippaehne W W, Fletcher W S. Prognostic value of estrogen receptor to endocrine ablation in cancer of the breast. Surg Gynecol Obstet 1974; 139: 525–528
- NIH Consensus Development Conference, Bethesda, Maryland, 1980; 2759–2963, Cancer (suppl 46)
- Gao Y L, Twiggs L B, Leung B S, et al. Cytoplasmic estrogen and progesterone receptors in primary cervical carcinoma: clinical and histopathological correlates. Am J Obstet Gynecol 1983; 146: 299–306
- Liao B S, Twiggs L B, Leung B S, et al. Cytoplasmic estrogen and progesterone receptor as prognostic indices in primary endometrial carcinoma. Am J Obstet Gynecol 1986; 67: 463–467
- Ehrlich C F, Young P CM, Cleary R E. Cytoplasmic progesterone and estradiol receptors in normal hyperplastic and carcinomatous endometria: Therapeutic implications. Am J Obstet Gynecol 1981; 141: 539–546
- Crearman W T, McCarty K S, Sr, Barton T K, et al. Clinical correlates of estrogen and progesterone-binding proteins in human endometrial adenocarcinoma. Obstet Gynecol 1980; 55: 363–370
- Menard S, Tagliabue E, Canevari S, et al. Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res 1983; 43: 1295–1300
- Bremer E G, Levery S B, Sonnino S, et al. Characterization of a glycosphingolipid antigen defined by the monoclonal antibodies MBrl expressed in normal and neoplastic epithelial cells of human mammary glands. J Biol Chem 1984; 259: 14773–14777
- Mariani-Costantini R, Colnaghi M I, Leoni F, et al. Immuno-histochemical reactivity of a monoclonal antibody prepared against human breast carcinoma. Virchows Arch [Pathol Anat] 1984; 402: 389–404
- Wang K C, Leung B S. Fluorometric ELISA method for screening of hybridomas producing anti-estrogen receptor antibodies. J Immunol Methods 1985; 84: 279–290
- Leung B S, Moseley H S, Davenport C E, . Estrogen receptor in prediction of clinical responses to endocrine ablation. Estrogen Receptors in Human Breast Cancer, W L McGuire, R P Carbone, E A Vollmer, et al. Raven Press, New York 1975; 107–129
- Yu W CY, Leung B S, Gao Y L. Effects of estradiol-17β on progesterone receptors and the uptake of thymidine in human breast cancer cell line, CAMA-1. Cancer Res 1981; 41: 5004–5009
- Lowry O H, Rosebrough N J, Farr A W, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–275
- Bjorn M J, Ring D, Frankel A. Evaluation of monoclonal antibodies for the development of breast cancer immunotoxins. Cancer Res 1985; 45: 1214–1221
- Hendler F J, Yuan D. Relationship of monoclonal antibody binding to estrogen and progesterone receptor content in breast cancer. Cancer Res 1985; 45: 421–429
- White C A, Dulbecco R, Allen R, et al. Two monoclonal antibodies selective for human mammary carcinoma. Cancer Res 1985; 45: 1337–1343
- Rasmussen B B, Peterson B V, Thorpe S M, et al. Prognostic value for surface antigens in primary breast carcinomas, detected by monoclonal antibodies. Cancer Res 1985; 45: 1424–1427
- Tagliabue E, Menard S, Torre G D, et al. Generation of monoclonal antibodies reacting with human epithelial ovarian cancer. Cancer Res 1985; 45: 379–385
- Tsuji Y, Suzuki T, Nishiura H, et al. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies. Cancer Res 1985; 45: 2358–2362
- Lanevari S, Fossati G, Balsari A, et al. Immunochemical analysis of the determinant recognized by a monoclonal antibody (MBr-1) which specifically binds to human mammary epithelial cells. Cancer Res 1983; 43: 1301–1305